DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,241 filers reported holding DANAHER CORPORATION in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,332,128 | -0.2% | 162,564 | -3.5% | 0.32% | +5.6% |
Q2 2023 | $40,427,760 | -6.1% | 168,449 | -1.3% | 0.30% | -4.7% |
Q1 2023 | $43,036,837 | -6.1% | 170,754 | -1.1% | 0.32% | -13.2% |
Q4 2022 | $45,839,096 | +1.1% | 172,704 | -1.6% | 0.36% | -6.2% |
Q3 2022 | $45,321,113 | +1.5% | 175,466 | -0.4% | 0.39% | +6.6% |
Q2 2022 | $44,655,773 | -12.8% | 176,143 | +0.9% | 0.36% | +7.4% |
Q1 2022 | $51,211,018 | +10.8% | 174,585 | +24.2% | 0.34% | -13.0% |
Q4 2021 | $46,230,511 | +5.8% | 140,514 | -2.1% | 0.39% | -3.5% |
Q3 2021 | $43,688,967 | +10.6% | 143,506 | -2.5% | 0.40% | +8.0% |
Q2 2021 | $39,497,225 | +16.2% | 147,180 | -2.6% | 0.38% | +16.5% |
Q1 2021 | $33,998,109 | -0.3% | 151,049 | -1.6% | 0.32% | -6.9% |
Q4 2020 | $34,107,820 | -1.1% | 153,542 | -4.1% | 0.35% | -8.5% |
Q3 2020 | $34,470,242 | +18.4% | 160,081 | -2.7% | 0.38% | +14.2% |
Q2 2020 | $29,101,267 | +27.6% | 164,572 | -0.1% | 0.33% | +3.1% |
Q1 2020 | $22,807,200 | -12.5% | 164,780 | -3.0% | 0.32% | +18.0% |
Q4 2019 | $26,064,281 | +3.9% | 169,822 | -2.3% | 0.27% | -4.9% |
Q3 2019 | $25,094,424 | +1.1% | 173,748 | +0.1% | 0.29% | +3.6% |
Q2 2019 | $24,819,344 | +5.3% | 173,659 | -2.8% | 0.28% | +3.8% |
Q1 2019 | $23,578,904 | +29.6% | 178,601 | +1.3% | 0.27% | +16.7% |
Q4 2018 | $18,189,749 | -6.6% | 176,394 | -1.5% | 0.23% | +10.7% |
Q3 2018 | $19,465,244 | +9.0% | 179,139 | -1.0% | 0.21% | -2.4% |
Q2 2018 | $17,858,000 | -1.3% | 180,967 | -2.0% | 0.21% | -0.9% |
Q1 2018 | $18,087,000 | +2.9% | 184,735 | -2.5% | 0.21% | +7.0% |
Q4 2017 | $17,580,000 | – | 189,399 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |